Literature DB >> 11761476

Cigarette smoking and the incidence of Parkinson's disease in two prospective studies.

M A Hernán1, S M Zhang, A M Rueda-deCastro, G A Colditz, F E Speizer, A Ascherio.   

Abstract

An inverse association between cigarette smoking and idiopathic Parkinson's disease has been reported in several retrospective studies, but prospective evidence is available only for men. We assessed the association between the incidence of Parkinson's disease and smoking in two large prospective cohort studies comprising men and women. New cases of Parkinson's disease were identified in the Nurses' Health Study for 1976-1996, and in the Health Professionals Follow-up Study for 1986-1996. Smoking history was assessed at baseline and updated on subsequent biennial questionnaires. In women, the age-adjusted rate ratios (95% confidence intervals) for Parkinson's disease relative to never-smokers were 0.7 (0.5, 1.0) for past smokers, and 0.4 (0.2, 0.7) for current smokers. In men, the age-adjusted rate ratios for Parkinson's disease relative to never-smokers were 0.5 (0.4, 0.7) for past smokers, and 0.3 (0.1, 0.8) for current smokers. In both cohorts, the strength of the association decreased with time since quitting (among past smokers), increased with number of cigarettes per day (among current smokers), and increased with pack-years of smoking. These prospective findings confirm that an inverse association between smoking and the incidence of Parkinson's disease exists in both men and women.

Entities:  

Mesh:

Year:  2001        PMID: 11761476     DOI: 10.1002/ana.10028

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  55 in total

1.  Tobacco, coffee, and Parkinson's disease.

Authors:  Catharine Gale; Christopher Martyn; Chris Gale
Journal:  BMJ       Date:  2003-03-15

Review 2.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

3.  Alleviation of severe restless legs syndrome (RLS) symptoms by cigarette smoking.

Authors:  Arie Oksenberg
Journal:  J Clin Sleep Med       Date:  2010-10-15       Impact factor: 4.062

4.  [First, do no harm...to smoke or not to smoke].

Authors:  J Reyes-Balaguer
Journal:  Aten Primaria       Date:  2005-12       Impact factor: 1.137

Review 5.  Improvement of restless legs syndrome by varenicline as antismoking treatment.

Authors:  Andrea Romigi; Giuseppe Vitrani
Journal:  J Clin Sleep Med       Date:  2013-10-15       Impact factor: 4.062

6.  Projection of the prevalence of Parkinson's disease in the coming decades: Revisited.

Authors:  Alexander Rossi; Kristin Berger; Honglei Chen; Douglas Leslie; Richard B Mailman; Xuemei Huang
Journal:  Mov Disord       Date:  2017-06-07       Impact factor: 10.338

7.  Reply to: Diabetes and risk of Parkinson's disease.

Authors:  Natalia Palacios; Alberto Ascherio
Journal:  Mov Disord       Date:  2013-02       Impact factor: 10.338

8.  Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Honglei Chen; Thomas H Mosley; Alvaro Alonso; Xuemei Huang
Journal:  Am J Epidemiol       Date:  2009-03-18       Impact factor: 4.897

9.  Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study.

Authors:  Louis C Tan; Woon-Puay Koh; Jian-Min Yuan; Renwei Wang; Wing-Lok Au; June H Tan; Eng-King Tan; Mimi C Yu
Journal:  Am J Epidemiol       Date:  2007-12-20       Impact factor: 4.897

10.  Effects of nicotine and mecamylamine on cognition in rhesus monkeys.

Authors:  Simon N Katner; Sophia A Davis; Amber J Kirsten; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.